The largest subsegment of this market in 2024 was the lateral lumbar interbody fusion (LLIF). It is expected that all subsegments keep growing in value with the MIPLIF being the fastest growing. On the other hand, MIPLIF has the smallest market value share because of a high decline in prices.
The full report suite on the global market for MIS interbody devices includes subsegments for the minimally invasive interbody devices such as minimally invasive posterior lumbar interbody fusion (MIPLIF), minimally invasive transforaminal lumbar interbody fusion (MITLIF), lateral lumbar interbody fusion (LLIF) and oblique lateral interbody (OLIF).
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
MARKET REPORT DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2031, and Historical Data to 2024
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitor
GLOBAL MIS INTERBODY DEVICE MARKET TRENDS
The major driver of this market is the increase in the elderly population relative to younger demographics and the tendency of the patients and surgeons for less invasive surgeries, as they result in less recovery time and less damage to the muscles and tissues.
Global Market Share Insights
1. 1. Globus Medical / NuVasive
Leading competitor in the total MIS interbody device market.
Strengthened by the merger in early 2023.
Held leading share in North America, Western Europe and Rest of the World.
2. 2. Medtronic
Second leading competitor in the market.
Presence supported by Direct Lateral Interbody Fusion (DLIF®).
Held second-largest share in all regions reported.
3. 3. DePuy Synthes
Third-leading competitor globally.
Future growth depends on innovation in the MIS market.
Held third position in all regions reported.
Research Scope Summary
Regions
North America (Canada, United States)
Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year:
2024
Forecast Period:
2025–2031
Historical Data:
2021–2023
Quantitative Data
Market Size
Market Shares
Market Forecasts
Market Growth Rates
Units Sold
Average Selling Prices
Qualitative Data
Market Growth Trends
Market Limiters
Competitive Analysis & SWOT for Top Competitors
Mergers & Acquisitions
Company Profiles
Product Portfolios
FDA Recalls
Disruptive Technologies
Disease Overviews
Data Sources
Primary Interviews with Industry Leaders
Government Physician Data
Regulatory Data
Hospital Private Data
Import & Export Data
iData Research Internal Database
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook